Collectively, these results suggest that measurement of CD44 level could facilitate early diagnosis of active LN, especially in patients in whom conventional serological markers do not appear helpful, and may also be useful in monitoring treatment response and histopathological changes in the kidney. Here, CD44 is linked to lobular neoplasia.